Dr. Jim Olson, Fred Hutchinson Cancer Research Center
Chair of the Children's Oncology Group (COG) national Phase III clinical trial of retinoic acid derivatives in medulloblastoma.
Specialty: Pediatric brain tumors
Attending the conference is free. There is a nominal food/incidentals charge which may be waived.
For more information, please email John Williams at john @ BrainTumorConference.com (remove spaces in the email address).